1 |
Biscaro A, Braga A, Berkowitz RS (2015). Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet, 37, 42-51.
DOI
|
2 |
Chapman-Davis E, Hoekstra AV, Rademaker AW,et la (2012). Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. Gynecol Oncol, 125, 572-5.
DOI
|
3 |
Froeling FE, Seckl MJ (2014). Gestational trophoblastic tumours: an update for 2014. Curr Oncol Rep, 16, 408-18.
DOI
|
4 |
Gilani MM, Fariba B, Behtash N, et al (2013). The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate. J Cancer Res Ther, 9, 38-43.
DOI
|
5 |
Gamer EI, Garrett A, Goldstein DP, et al (2004). Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. J Reprod Med, 49, 411-4.
|
6 |
Maesta I, Growdon WB, Goldstein DP,et al (2013). Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol, 130, 312-6.
DOI
|
7 |
Manopunya M, Suprasert P (2012). Resistant gestational trophoblastic neoplasia patients treated with 5-fluorouracil plus actinomycin D. Asian Pac J Cancer Prev, 13, 387-90.
DOI
ScienceOn
|
8 |
May T, Goldstein DP, Berkowitz RS,et al (2011). Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract, 2011, 1-12.
|
9 |
Ngan HY, Kohorn EI, Cole LA,et al (2012). Trophoblastic disease. Int J Gynaecol Obstet, 119, 130-6.
DOI
|
10 |
Ozalp SS, Telli E, Oge T, et al (2014). Multicenter analysis of gestational trophoblastic neoplasia in Turkey. Asian Pac J Cancer Prev, 15, 3625-8.
DOI
|
11 |
Seckl MJ, Sebire NJ, Fisher RA,et al (2013). Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 24, 39-50.
|
12 |
Taylor F, Short D, Winter MC,et al (2015). A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom. Gynecol Oncol, 136, 258-63.
DOI
|